Back to CHARLES SCHWAB INVESTMENT MANAGEMENT INC CHARLES SCHWAB INVESTMENT MANAGEMENT INC

TVGNTVGN

Showing 7 of 8 quarters

Position history for CHARLES SCHWAB INVESTMENT MANAGEMENT INCCHARLES SCHWAB INVESTMENT MANAGEMENT INC's holdings in <![CDATA[TEVOGEN BIO HOLDINGS INC]]>

As of its Q4 2025 13F, Charles Schwab Investment Management held 82,114 shares of TVGN (<![cdata[tevogen Bio Holdings Inc]]>), worth $27,188. Charles Schwab Investment Management's 13F filings listed TVGN from Q2 2024 to Q4 2025, 7 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$18,266

Total Shares Change

-49,581

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$4.52
0
2025-Q4
Increased
82,114
+7.4%
$27,1880.0%$16.55
14
2025-Q3
Unchanged
76,475
0.0%
$60,0560.0%$39.25
0
2025-Q2
Increased
76,475
+54.0%
$95,5940.0%$62.50
21
2025-Q1
Increased
49,644
+0.1%
$53,6160.0%$54.00
14
2024-Q4
Unchanged
49,581
0.0%
$51,0680.0%$51.50
0
2024-Q3
Unchanged
49,581
0.0%
$18,2660.0%$18.40
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used